These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35569003)

  • 21. A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone.
    Perez-Iglesias R; Crespo-Facorro B; Amado JA; Garcia-Unzueta MT; Ramirez-Bonilla ML; Gonzalez-Blanch C; Martinez-Garcia O; Vazquez-Barquero JL
    J Clin Psychiatry; 2007 Nov; 68(11):1733-40. PubMed ID: 18052567
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of treatment algorithms including amantadine, metformin, and zonisamide for the prevention of weight gain with olanzapine: a randomized controlled open-label study.
    Hoffmann VP; Case M; Jacobson JG
    J Clin Psychiatry; 2012 Feb; 73(2):216-23. PubMed ID: 21672497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nizatidine treatment and its relationship with leptin levels in patients with olanzapine-induced weight gain.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    Hum Psychopharmacol; 2003 Aug; 18(6):457-61. PubMed ID: 12923824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amisulpride, aripiprazole, and olanzapine in patients with schizophrenia-spectrum disorders (BeSt InTro): a pragmatic, rater-blind, semi-randomised trial.
    Johnsen E; Kroken RA; Løberg EM; Rettenbacher M; Joa I; Larsen TK; Reitan SK; Walla B; Alisauskiene R; Anda LG; Bartz-Johannessen C; Berle JØ; Bjarke J; Fathian F; Hugdahl K; Kjelby E; Sinkeviciute I; Skrede S; Stabell L; Steen VM; Fleischhacker WW
    Lancet Psychiatry; 2020 Nov; 7(11):945-954. PubMed ID: 33069317
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study.
    Li YM; Zhao JP; Ou JJ; Wu RR
    Pharmacopsychiatry; 2012 Jul; 45(5):177-81. PubMed ID: 22290206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine.
    Assunção SS; Ruschel SI; Rosa Lde C; Campos JA; Alves MJ; Bracco OL; de Lima MS
    Braz J Psychiatry; 2006 Dec; 28(4):270-6. PubMed ID: 17242805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
    CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Naturalistic Randomized Placebo-Controlled Trial of Extended-Release Metformin to Prevent Weight Gain Associated With Olanzapine in a US Community-Dwelling Population.
    Rado J; von Ammon Cavanaugh S
    J Clin Psychopharmacol; 2016 Apr; 36(2):163-8. PubMed ID: 26872112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Randomized comparison of olanzapine versus risperidone for the treatment of first-episode schizophrenia: 4-month outcomes.
    Robinson DG; Woerner MG; Napolitano B; Patel RC; Sevy SM; Gunduz-Bruce H; Soto-Perello JM; Mendelowitz A; Khadivi A; Miller R; McCormack J; Lorell BS; Lesser ML; Schooler NR; Kane JM
    Am J Psychiatry; 2006 Dec; 163(12):2096-102. PubMed ID: 17151160
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriate intervention strategies for weight gain induced by olanzapine: a randomized controlled study.
    Milano W; Grillo F; Del Mastro A; De Rosa M; Sanseverino B; Petrella C; Capasso A
    Adv Ther; 2007; 24(1):123-34. PubMed ID: 17526469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.
    Praharaj SK; Jana AK; Goyal N; Sinha VK
    Br J Clin Pharmacol; 2011 Mar; 71(3):377-82. PubMed ID: 21284696
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine for schizophrenia.
    Duggan L; Fenton M; Rathbone J; Dardennes R; El-Dosoky A; Indran S
    Cochrane Database Syst Rev; 2005 Apr; (2):CD001359. PubMed ID: 15846619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and Short-term Safety of ALKS 3831, a Fixed-dose Combination of Olanzapine and Samidorphan, in Adult Subjects with Schizophrenia.
    Sun L; McDonnell D; von Moltke L
    Clin Ther; 2018 Nov; 40(11):1845-1854.e2. PubMed ID: 30348514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
    J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Miricorilant, a Selective Glucocorticoid Receptor Modulator, on Olanzapine-Associated Weight Gain in Healthy Subjects: A Proof-of-Concept Study.
    Hunt HJ; Donaldson K; Strem M; Tudor IC; Sweet-Smith S; Sidhu S
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):632-637. PubMed ID: 34369902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ranitidine in olanzapine-induced weight gain: a dose-response study.
    Mehta VS; Ram D
    Early Interv Psychiatry; 2016 Dec; 10(6):522-527. PubMed ID: 25529756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weight gain and changes in metabolic variables following olanzapine treatment in schizophrenia and bipolar disorder.
    Citrome L; Holt RI; Walker DJ; Hoffmann VP
    Clin Drug Investig; 2011; 31(7):455-82. PubMed ID: 21495734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Attenuation of antipsychotic-induced weight gain with early behavioral intervention in drug-naive first-episode psychosis patients: A randomized controlled trial.
    Alvarez-Jiménez M; González-Blanch C; Vázquez-Barquero JL; Pérez-Iglesias R; Martínez-García O; Pérez-Pardal T; Ramírez-Bonilla ML; Crespo-Facorro B
    J Clin Psychiatry; 2006 Aug; 67(8):1253-60. PubMed ID: 16965204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis.
    Templeman LA; Reynolds GP; Arranz B; San L
    Pharmacogenet Genomics; 2005 Apr; 15(4):195-200. PubMed ID: 15864111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.